Oramed to Present at BIT’S 5th World Congress of Diabetes on July 13, 2017

JERUSALEM, July 12, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Dr. Miriam Kidron, Oramed’s Chief Scientific Officer, will deliver a presentation titled, “Oral Insulin for Diabetes Treatment: Bypassing the Roadblock” at the upcoming BIT’S 5th World Congress […]